Life-changing Drug Trikafta Submitted to Health Canada for Ages Six to Eleven
Read More
News
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
MANITOBA BECOMES FINAL PROVINCE TO COMMIT TO LIST LIFE CHANGING CYTIC FIBROSIS DRUG
CF Canada calls on the Northwest Territories, Nunavut and Federal Drug Programs to Fund Trikafta
Read MoreNEWFOUNDLAND AND LABRADOR HONOURS COMMITMENT TO FUND CYSTIC FIBROSIS DRUG TRIKAFTA
All Atlantic Canada provinces have confirmed commitment to fund the drug
Read MoreYUKON MAKES HISTORY AS FIRST TERRITORY TO FUND TRIKAFTA
Cystic Fibrosis Canada calls on remaining jurisdictions to fund the drug
Read MorePEI HONOURS COMMITMENT TO FUND CYSTIC FIBROSIS DRUG TRIKAFTA
Newfoundland and Labrador is the only Atlantic Canada province yet to confirm it will fund the drug. Prince Edward Island (PEI) is the latest province to announce it will fund the transformational cystic fibrosis drug, Trikafta.
Read MoreBritish Columbia Becomes Fifth Province to List Miracle Cystic Fibrosis Drug, Trikafta
Read More
Open letter from CF clinicians calling upon provincial governments to make Trikafta accessible to everyone who could benefit from it
Over 50 CF medical experts from across Canada have added their names to the open letter to provincial governments calling for access for everyone who could benefit from it.
Read MoreCystic Fibrosis Canada launches Elevate to ensure work is guided by people impacted by disease
Community consultation program will enable people impacted by cystic fibrosis to provide input, insights and perspectives
Read MoreQuebec lists Trikafta for reimbursement, offering new hope for Quebecers living with Cystic fibrosis
Cystic Fibrosis Canada calls on remaining provinces to save lives and list Trikafta immediately
Read MoreCystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs
Cystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs
Read More